pyrazolanthrone has been researched along with Peripheral Nerve Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cho, MC; Kim, SW; Lee, J | 1 |
Chen, L; Cui, SS; Gao, J; Liu, F; Lu, R; Wang, W; Wang, XX | 1 |
2 other study(ies) available for pyrazolanthrone and Peripheral Nerve Injuries
Article | Year |
---|---|
Combination Therapy with a JNK Inhibitor and Hepatocyte Growth Factor for Restoration of Erectile Function in a Rat Model of Cavernosal Nerve Injury: Comparison with a JNK Inhibitor Alone or Hepatocyte Growth Factor Alone.
Topics: Animals; Anthracenes; Drug Therapy, Combination; Erectile Dysfunction; Hepatocyte Growth Factor; Male; MAP Kinase Kinase 4; Nerve Crush; Penile Erection; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley | 2021 |
Astrocytic c-Jun N-terminal kinase-histone deacetylase-2 cascade contributes to glutamate transporter-1 decrease and mechanical allodynia following peripheral nerve injury in rats.
Topics: Animals; Anthracenes; Astrocytes; Carbamates; Cells, Cultured; Etanercept; Excitatory Amino Acid Transporter 2; Histone Deacetylase 2; Hyperalgesia; JNK Mitogen-Activated Protein Kinases; Male; Microglia; Minocycline; Neuralgia; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Nerves; Tumor Necrosis Factor-alpha | 2021 |